FDA recommends that audit trails that capture changes to critical data be reviewed with
each record and before final approval of the record. Audit trails subject to regular review
should include, but are not limited to, the following: the change history of finished
product test results, changes to sample run sequences, changes to sample identification,
and changes to critical process parameters.
